Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Serum calcium, phosphate, and 1,25‐dihydroxyvitamin D3 [1,25‐(OH)2D3] levels were comparable between WT and KLhet mice (Figure S1).

Source: Elevated Serum Potassium and Reduced Urinary Potassium Excretion in KLhet Mice. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Animal research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Sixteen‐week‐old mice were used.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Klotho Deficiency Impairs Distal Potassium Homeostasis Through mTORC1‐Dependent Suppression of ROMK

Study design awaiting verification · Acta Physiologica (Oxford, England) · 2026

Original publication title

Klotho Deficiency Impairs Distal Potassium Homeostasis Through mTORC1‐Dependent Suppression of ROMK

Wakako Kawarazaki; Nobuhiro Ayuzawa; Mitsuhiro Nishimoto; Daigoro Hirohama; Kohei Ueda; Takeshi Marumo; Toshiro Fujita

© 2026 The Author(s). Acta Physiologica published by John Wiley & Sons Ltd on behalf of Scandinavian Physiological Society.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Klotho deficiency impairs renal potassium handling through mTORC1‐dependent downregulation of ROMK, with compensatory hyperaldosteronism and ENaC activation. These findings highlight an important role of the Klotho: mTORC1 axis in distal potassium homeostasis and its potential as a therapeutic target for Klotho deficiency: associated hyperkalemia.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Hyperkalemia is prevalent in the elderly, and underlying molecular mechanisms remain incompletely understood. We hypothesized that Klotho deficiency, a feature of aging, impairs renal potassium homeostasis and contributes to hyperkalemia.

Source: Aim

Abstract: What methods does the paper describe?

Klotho heterozygous knockout (KLhet) mice, characterized by reduced Klotho levels, were used to investigate determinants of potassium handling, including renal outer medullary potassium channel (ROMK)1, the epithelial sodium channel (ENaC), which provides the driving force for ROMK‐mediated potassium secretion, and plasma aldosterone concentration (PAC).

Source: Methods

Abstract: Results

KLhet mice developed hyperkalemia with reduced urinary potassium excretion, accompanied by activation of renal mechanistic target of rapamycin complex 1 (mTORC1) signaling, indicated by increased phosphorylated S6, and decreased ROMK1 abundance in the plasma membrane fraction. Adrenal expression of aldosterone synthase Cyp11b2 and PAC were elevated, and ENaC activity was enhanced, as evidenced by increased cleavage of α‐ and γ‐ENaC subunits, partially compensating for impaired potassium excretion. Pharmacological ENaC inhibition with amiloride precipitated severe hyperkalemia in KLhet mice. In contrast, treatment with the mTORC1 inhibitor rapamycin or Klotho supplementation suppressed renal mTORC1 signaling, restored plasma membrane ROMK1 abundance, increased urinary potassium excretion, and normalized serum potassium levels, with reduced Cyp11b2 expression.

Source: Results

Abstract: Conclusion

Klotho deficiency impairs renal potassium handling through mTORC1‐dependent downregulation of ROMK, with compensatory hyperaldosteronism and ENaC activation. These findings highlight an important role of the Klotho: mTORC1 axis in distal potassium homeostasis and its potential as a therapeutic target for Klotho deficiency: associated hyperkalemia.

Source: Conclusion
Authors’ abstract

ABSTRACT

Aim

Hyperkalemia is prevalent in the elderly, and underlying molecular mechanisms remain incompletely understood. We hypothesized that Klotho deficiency, a feature of aging, impairs renal potassium homeostasis and contributes to hyperkalemia.

Methods

Klotho heterozygous knockout (KLhet) mice, characterized by reduced Klotho levels, were used to investigate determinants of potassium handling, including renal outer medullary potassium channel (ROMK)1, the epithelial sodium channel (ENaC), which provides the driving force for ROMK‐mediated potassium secretion, and plasma aldosterone concentration (PAC).

Results

KLhet mice developed hyperkalemia with reduced urinary potassium excretion, accompanied by activation of renal mechanistic target of rapamycin complex 1 (mTORC1) signaling, indicated by increased phosphorylated S6, and decreased ROMK1 abundance in the plasma membrane fraction. Adrenal expression of aldosterone synthase Cyp11b2 and PAC were elevated, and ENaC activity was enhanced, as evidenced by increased cleavage of α‐ and γ‐ENaC subunits, partially compensating for impaired potassium excretion. Pharmacological ENaC inhibition with amiloride precipitated severe hyperkalemia in KLhet mice. In contrast, treatment with the mTORC1 inhibitor rapamycin or Klotho supplementation suppressed renal mTORC1 signaling, restored plasma membrane ROMK1 abundance, increased urinary potassium excretion, and normalized serum potassium levels, with reduced Cyp11b2 expression.

Conclusion

Klotho deficiency impairs renal potassium handling through mTORC1‐dependent downregulation of ROMK, with compensatory hyperaldosteronism and ENaC activation. These findings highlight an important role of the Klotho: mTORC1 axis in distal potassium homeostasis and its potential as a therapeutic target for Klotho deficiency: associated hyperkalemia.

Keywords:

aldosterone, distal nephron, hyperkalemia, Klotho, mTORC1, renin: angiotensin system, ROMK

Practioner Points

  • Klotho deficiency impaired urinary potassium excretion and caused hyperkalemia, accompanied by activation of renal mTORC1 signaling and reduced plasma membrane abundance of ROMK in the distal nephron.

  • These alterations were associated with compensatory hyperaldosteronism and ENaC activation, while pharmacological ENaC inhibition further exacerbated hyperkalemia.

  • Both mTORC1 inhibition with rapamycin and Klotho supplementation restored plasma membrane ROMK abundance in the distal nephron, improved potassium excretion, and normalized serum potassium levels, highlighting an important role of the Klotho: mTORC1: ROMK axis in renal potassium homeostasis.

Publication and source details

Original title: Klotho Deficiency Impairs Distal Potassium Homeostasis Through mTORC1‐Dependent Suppression of ROMK

Wakako Kawarazaki; Nobuhiro Ayuzawa; Mitsuhiro Nishimoto; Daigoro Hirohama; Kohei Ueda; Takeshi Marumo; Toshiro Fujita

Acta Physiologica (Oxford, England) · 2026

*

Correspondence: Wakako Kawarazaki (wkawarazaki-tky@umin.ac.jp; kawarazaki@ihwg.jp)

✉

Corresponding author.

© 2026 The Author(s). Acta Physiologica published by John Wiley & Sons Ltd on behalf of Scandinavian Physiological Society.This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T20:32:46.384765+00:00

DOI: 10.1111/apha.70325 · PMC13635471